Share：
Share this content in WeChat
X
[Chinese][PDF]73885
• Original Article •
Preparation of folate-mediated superparamagnetic iron oxide-dopamine-folate and its in vitro MR imaging
TANG Na  ZHAO Guang-ming  LI Zheng-yu  ZHANG Gui-xiang  WANG Zhong-ling 

DOI:10.12015/issn.1674-8034.2017.08.009.


[Abstract] Objective: To observe the targeting function of folate-conjugated superparamagnetic iron oxide-dopamine (NP-DA-Dextra-FA) to Bel7402 cells by folate receptor (FR) and the possibility for monitoring tumor targeting with MRI.Materials and Methods: NP-DA-Dextra-FA and NP-DA-Dextran were hatched with Bel7402 cells for 2 h, separately. Prussian blue staining was used to survey intracellular irons, meanwhile MRI was used to research the signal intensity of cells. The competitive inhibition test was performed.Results: The experimental group showed the T2WI signal intensity of Bel7402 cells declined significantly with the rise of NP-DA-Dextra-FA’s iron concentration. A lot of intracellular irons were observed in Bel7402 cells. The control group showed the signal intensity of Bel7402 cells on T2WI decreased less clearly. Some intracellular irons were showed in Bel7402 cells. The competitive inhibition test showed the T2WI signal intensity increased with the folic acid concentration rising.Conclusion: In vitro, the NP-DA-Dextra-FA has obvious targeting ability to Bel7402 cells. The cell targeting processes could be supervised with MRI.
[Keywords] Carcinoma, hepatocellular；Folic acid；Targeting imaging；Magnetic resonance imaging；Molecular probes

TANG Na Department of Radiology, The First People's Hospital of Shanghai, Shanghai 200085, China

ZHAO Guang-ming Department of Radiology, The First People's Hospital of Shanghai, Shanghai 200085, China

LI Zheng-yu Department of Radiology, The First People's Hospital of Shanghai, Shanghai 200085, China

ZHANG Gui-xiang Department of Radiology, The First People's Hospital of Shanghai, Shanghai 200085, China

WANG Zhong-ling* Department of Radiology, The First People's Hospital of Shanghai, Shanghai 200085, China

*Correspondence to: Wang ZL, E-mail: zlwang138136@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Natural Science Foundation of China No. 81371623
Received  2017-02-04
Accepted  2017-06-12
DOI: 10.12015/issn.1674-8034.2017.08.009
DOI:10.12015/issn.1674-8034.2017.08.009.

[1]
Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory. Acc Chem Res, 2008, 41(1): 120-129.
[2]
Low PS, Antony AC. Folate receptor-targeted drugs for cancer and inflammatory diseases. Adv Drug Delivery Rev, 2004, 56(8): 1055-1058.
[3]
Miotti S, Bagnoli M, Ottone F, et al. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. J Cell Biochem, 1997, 65(4): 479-491.
[4]
Toffoli G, Cernigoi C, Russo A, et al. Overexpression of folate binding protein in ovarian cancers. Int J Cancer, 1997, 74(2): 193-198.
[5]
Kamaly N, Kalber T, Thanou M, et al. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjug Chem, 2009, 20(4): 648-655.
[6]
Wu J, Liu Q, Lee RJ. Folate receptor-targeted liposomal formulation for paclitaxel. Int J Pharm, 2006, 316(1-2): 148-153.
[7]
Meier R, Henning TD, Boddington S, et al. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. Radiology, 2010, 255(2): 527-535.
[8]
Ding JH, Zeng MS, Xue Q, et al. An experimental study of the diagnosing value to nude mice model of transplanted human gastric cancer with folate-receptor MR contrast agent. Chin J Radiol, 2005, 39(8): 882-886.丁建辉，曾蒙苏，薛琼，等．叶酸受体型MR对比剂在荷人胃癌裸鼠诊断价值的实验研究．中华放射学杂志，2005，39(8)：882-886．
[9]
Wang ZL, Guo L, Li YG, et al. Preparation of folate-mediated superparamagnetic iron oxide-dopamine-folate and its in vitro MR imaging. Chin J Med Imaging Technol, 2011, 27(2): 251-255.王中领，郭亮，李勇刚，等．叶酸靶向超顺磁性氧化铁-多巴胺-叶酸纳米复合物的制备及体外成像．中国医学影像技术，2011，27(2)：251-255．
[10]
Li KA, Zhang F, Ma YJ. In vivo MR imging and pathology study in mice model labeled with SPIO. Chin J Med Imaging Technol, 2005, 21(11): 1655-1658.李康安，张峰，马勇杰．SPIO分子探针标记裸鼠肺腺癌移植瘤的磁共振成像及病理学初步研究．中国医学影像技术，2005，21(11)：1655-1658．
[11]
Daldrup HE, Rydland J, Helbich TH, et al. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: Initial phase Ⅱ multicenter trial. Radiology, 2003, 229(3): 885-892.
[12]
Bhattacharya D, Das M, Mishra D, et al. Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging. Nanoscale, 2011, 3(4): 1653-1662.
[13]
Schlorf T, Meincke M, Kossel E, et al. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Int J Mol Sci, 2010, 12(1): 12-23.
[14]
Kohler N, Sun C, Wang J, et al. Methotrexate-modified superparamagnetic nanoparticle and their intracellular uptake into human cancer cells. Langmuir, 2005, 21(19): 8858-8864.

PREV he effect of economic status on responses to unfairness: A rs-fMRI study
NEXT Field map-based rectification of susceptibility distortion and signal compensation in diffusion tensor imaging
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn